AbCellera Biologics (ABCL) Other Working Capital Changes (2020 - 2025)
AbCellera Biologics' Other Working Capital Changes history spans 6 years, with the latest figure at -$4.5 million for Q4 2025.
- For the quarter ending Q4 2025, Other Working Capital Changes rose 8.79% year-over-year to -$4.5 million, compared with a TTM value of -$2.2 million through Dec 2025, up 63.13%, and an annual FY2025 reading of -$2.2 million, up 63.13% over the prior year.
- Other Working Capital Changes for Q4 2025 was -$4.5 million at AbCellera Biologics, down from $15.8 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $15.8 million in Q3 2025, with the low at -$26.8 million in Q2 2025.
- Average Other Working Capital Changes over 5 years is -$579750.0, with a median of -$828500.0 recorded in 2021.
- Year-over-year, Other Working Capital Changes surged 1260.89% in 2022 and then crashed 461.66% in 2025.
- Tracing ABCL's Other Working Capital Changes over 5 years: stood at -$427000.0 in 2021, then surged by 1260.89% to $5.0 million in 2022, then tumbled by 322.21% to -$11.0 million in 2023, then surged by 55.1% to -$4.9 million in 2024, then increased by 8.79% to -$4.5 million in 2025.
- Per Business Quant, the three most recent readings for ABCL's Other Working Capital Changes are -$4.5 million (Q4 2025), $15.8 million (Q3 2025), and -$26.8 million (Q2 2025).